scholarly journals Predicting Dialysis Fistula Maturation Using the “Rule of 6’S”—Not All are Created Equal

2021 ◽  
Vol 74 (4) ◽  
pp. e411-e412
Author(s):  
Anne J. Hakim ◽  
Benjamin S. Brooke ◽  
Julie L. Beckstrom ◽  
Mark R. Sarfati ◽  
Larry W. Kraiss
2019 ◽  
Vol 21 (1) ◽  
pp. 105-109
Author(s):  
Sigi Nauwelaers ◽  
Wouter Lansink ◽  
Herman Schroë ◽  
Geert Lauwers

Non-maturation of arteriovenous fistulas is a frequent problem after dialysis access creation, especially in the forearm. The presence of accessory veins may play an important role in the non-maturing fistula. Several surgical and endovascular techniques are described to deal with this problem. We describe a new surgical technique in which we perform a rejoining of the arm veins to create a single large run-off vessel with greater diameter and flow for haemodialysis.


2021 ◽  
pp. 112972982096506
Author(s):  
Eva Chytilova ◽  
Tamara Jemcov ◽  
Jan Malik ◽  
Jernej Pajek ◽  
Branko Fila ◽  
...  

The goal of vascular access creation is to achieve a functioning arteriovenous fistula (AVF) or arteriovenous graft (AVG). An autologous fistula has been shown to be superior to AVG or to central venous catheters (CVCs) with lowest rate of re-intervention, but vessel obstruction or immaturity accounts for 20 % to 54% of cases with primary failure of AVF. This review is focused on the factors influencing maturation; indication and timing of preoperative mapping/creation of vascular access; ultrasound parameters for creation AVF/AVG; early postoperative complications following creation of a vascular access; ultrasound determinants of fistula maturation and endovascular intervention in vascular access with maturation failure. However, vascular accesses that fail to develop, have a high incidence of correctable abnormalities, and these need to be promptly recognized by ultrasonography and managed effectively if a high success rate is to be expected. We review approaches to promoting fistula maturation and duplex ultrasonography (DUS) of evaluating vascular access maturation.


Author(s):  
Rym El Khoury ◽  
Andrew P. Russeau ◽  
Neil Patel ◽  
Firas Dabbous ◽  
Irina Kechker ◽  
...  

2017 ◽  
Vol 66 (3) ◽  
pp. e53-e54
Author(s):  
Jonathan Misskey ◽  
Ramin Hamidizadeh ◽  
Jerry Chen ◽  
Jason Faulds ◽  
Joel Gagnon ◽  
...  
Keyword(s):  

2016 ◽  
Vol 17 (3) ◽  
pp. 229-232 ◽  
Author(s):  
Julien Al Shakarchi ◽  
Damian McGrogan ◽  
Sabine Van der Veer ◽  
Matthew Sperrin ◽  
Nicholas Inston

2017 ◽  
Vol 18 (1_suppl) ◽  
pp. S114-S117 ◽  
Author(s):  
Bram M. Voorzaat ◽  
Jan van Schaik ◽  
Koen E.A. van der Bogt ◽  
Liffert Vogt ◽  
Laurens Huisman ◽  
...  

Background Non-maturation is a frequent complication of radiocephalic arteriovenous fistulas (RCAVF). In an animal model, liposomal prednisolone improved maturation of experimental fistulas. The Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (LIPMAT) study investigates if liposomal prednisolone improves RCAVF maturation. Methods and results The LIPMAT study is an investigator-initiated, multicenter, double-blinded, placebo-controlled randomized controlled trial with 1:1 randomization to liposomal prednisolone or placebo. Eighty patients receiving an RCAVF will be included. The primary outcome is the cephalic vein diameter six weeks after surgery, measured by ultrasound. The LIPMAT study started in May 2016. Enrollment is expected to be completed by the end of 2017. Conclusions The LIPMAT study is the first to evaluate the efficacy of liposomal prednisolone to enhance RCAVF maturation.


Sign in / Sign up

Export Citation Format

Share Document